Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 3, 2000, Pages 315-320

  Cabellos, C ^b   Martinez Lacasa J ^b   Tubau, F ^a   Fernandez A ^b   Viladrich, P F ^b   Linares J ^a   Gudiol, F ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RABBIT; STREPTOCOCCUS PNEUMONIAE; TIME; TREATMENT FAILURE;

EID: 0342904949     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.3.315     Document Type: Article

References (19)

1. Klugman, K. P., Friedland, I. R. & Bradley, J. S. (1995). Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrobial Agents and Chemotherapy 39, 1988-92.
2. Liñares, J., Alonso, T., Perez, J. L., Ayats, J., Dominguez, M. A., Pallares, R. et al. (1992). Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 30, 279-88.
3. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1994). Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem and vancomycin. Antimicrobial Agents and Chemotherapy 38, 898-900.
4. Viladrich, P. F., Gudiol, F., Liñares, J., Rufí, G., Ariza, J. & Pallarés, R. (1988). Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. American Journal of Medicine 84, 839-46.
5. Friedland, I. R., Paris, M., Ehrett, S., Hickey, S., Olsen, K. D. & McCracken, G. H., Jr (1993). Evaluation of antimicrobial regimens for treatment of experimental penicillin and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 37, 1630-6.
6. Viladrich, P. F., Cabellos, C., Pallares, R., Tubau, F., Martínez-Lacasa, J., Liñares, J. et al. (1996). High dose of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibility to broad spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 40, 218-20.
7. Girgis, N. I., Farid, Z., Mikhail, I. A., Farrag, I., Sulstan, Y. & Kilpatrick, M. E. (1989). Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Diseases Journal 8, 848-51.
8. Lebel, M. H., Freij, B. J., Syrogianopoulos, G. A., Chrane, D. F., Hoyt, M. J., Stewart, S. M. et al. (1988). Dexamethasone therapy for bacterial meningitis: results of two double blind, placebo controlled trials. New England Journal of Medicine 319, 964-71.
9. Odio, C. M., Faingezicht, I., Paris, M. I., Nassar, M., Baltodano, A., Rogers, J. et al. (1991). The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New England Journal of Medicine 324, 1525-31.
10. Schaad, U. B., Kaplan, S. L. & McCracken, G. H., Jr. (1995). Steroid therapy for bacterial meningitis. Clinical Infectious Diseases 20, 685-90.
11. Cabellos, C., Martínez-Lacasa, J., Martos, A., Tubau, F., Fernández, A., Viladrich, P. F. et al. (1995). Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 39, 2158-60.
12. Paris, M. M., Hickey, S. M., Uscher, M. I., Shelton, S., Olsen, K. D., McCracken, G. H., Jr (1994). Effect of dexamethasone on therapy of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 38, 1320-4.
13. Dacey, R. G. & Sande, M. A. (1974). Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivates. Antimicrobial Agents and Chemotherapy 6, 437-41.
14. National Committee for Clinical Laboratory Standards. (1999). Performance Standards for Antimicrobial Susceptibility Testing -Ninth Informational Supplement: M100-S9. NCCLS, Wayne, PA.
15. Chapin-Robertson, K. & Edberg, S. C. (1991). Measurements of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 3rd edn, (Lorian, V., Ed.), pp. 295-366. Williams & Wilkins, Baltimore.
16. Griffin, J. (1992). Serum inhibitory and bactericidal titers. In Clinical Microbiology Procedures Handbook, (Isenberg, H. D., Ed.), pp. 1-18. American Society for Microbiology, Washington, DC.
17. Knapp, C. & Moody, J. A. (1992). Test to assess bactericidal activity. In Clinical Microbiology Procedures Handbook, (Isenberg, H. D., Ed.), p. 12. American Society for Microbiology, Washington, DC.
18. Lutsar, I., Ahmed, A., Friedland, I. R., Trujillo, M., Wubbel, L., Olsen, K. et al. (1997). Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 41, 2414-7.
19. Vogelman, B., Gudmundsson, S., Legett, J., Turnidge, J., Ebert, S. & Craig, W. A. (1988). Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases 158, 831-47.